1.Bando, K, Turrentine, MW, Sharp, TG, et al.Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 1996; 112: 1600–1607; discussion 1607–1609.
2.Adatia, I, Atz, AM, Jonas, RA, Wessel, DL.Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 1996; 112: 1403–1405.
3.Curran, RD, Mavroudis, C, Backer, CL, Sautel, M, Zales, VR, Wessel, DL.Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995; 60: 1765–1771.
4.Atz, AM, Wessel, DL.Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 1997; 21: 441–455.
5.Wessel, DL, Adatia, I, Giglia, TM, Thompson, JE, Kulik, TJ.Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 2128–2138.
6.Beghetti, M, Silkoff, PE, Caramori, M, Holtby, HM, Slutsky, AS, Adatia, I.Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Surg 1998; 66: 532–534.
7.Mathru, M, Huda, R, Solanki, DR, Hays, S, Lang, JD.Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 2007; 106: 275–282.
8.Shah, S, Szmuszkovicz, JR.Pediatric perioperative pulmonary arterial hypertension: a case-based primer. Children (Basel) 2017; 4: 92.
9.Barr, FE, Macrae, D.Inhaled nitric oxide and related therapies. Pediatr Crit Care Med 2010; 11: S30–36.
10.Bizzarro, M, Gross, I, Barbosa, FT.Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2014: CD005055.
11.Beghetti, M, Habre, W, Friedli, B, Berner, M.Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65.
12.Morris, K, Beghetti, M, Petros, A, Adatia, I, Bohn, D.Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 2000; 28: 2974–2978.
13.Day, RW, Hawkins, JA, McGough, EC, Crezee, KL, Orsmond, GS.Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000; 69: 1907–1912; discussion 1913.
14.Shimpo, H, Mitani, Y, Tanaka, J, et al.Inhaled low-dose nitric oxide for postoperative care in patients with congenital heart defects. Artif Organs 1997; 21: 10–13.
15.Checchia, PA, Bronicki, RA, Muenzer, JT, et al.Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children – a randomized trial. J Thorac Cardiovasc Surg 2013; 146: 530–536.
16.James, C, Millar, J, Horton, S, Brizard, C, Molesworth, C, Butt, W.Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med 2016; 42: 1744–1752.
17.Checchia, PA, Bronicki, RA, Goldstein, B.Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Cardiol 2012; 33: 493–505.
18.Fullerton, DA, Jones, SD, Jaggers, J, Piedalue, F, Grover, FL, McIntyre, RC Jr. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation. J Thorac Cardiovasc Surg 1996; 111: 753–762; discussion 762–753.
19.Latus, H, Gerstner, B, Kerst, Get al.Effect of inhaled nitric oxide on blood flow dynamics in patients after the Fontan procedure using cardiovascular magnetic resonance flow measurements. Pediatr Cardiol 2016; 37: 504–511.
20.Todd Tzanetos, DR, Housley, JJ, Barr, FE, May, WL, Landers, CD.Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care 2015; 60: 644–650.